The health department has confirmed that it plans to defer almost two-thirds of the March PBAC meeting submissions while an impacted company has become the first to speak out.
Health department attempts to defer two-thirds of submissions to March meeting
October 24, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
GSK brings Melbourne discovered treatment 'home' to Australian patients
April 1, 2025 - - Latest News -
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease
April 1, 2025 - - Latest News -
Novo Nordisk forms Aboriginal and Torres Strait Islander Health Advisory Council
April 1, 2025 - - Latest News -
Ipsen welcomes TGA registration of treatment for primary biliary cholangitis
April 1, 2025 - - Latest News -
Opthea announces decision to discontinue wet-AMD clinical trials
March 31, 2025 - - Australian Biotech -
BioNSW launches BioInvest Catalyst events to support life sciences investment in NSW
March 31, 2025 - - Australian Biotech -
New government report reveals the emerging impact of generational reform
March 31, 2025 - - Latest News